BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7303501)

  • 1. [The effect of probucol of bile composition].
    Marecek Z; Jirsa M; Kordac V; Kucerová K
    Vnitr Lek; 1981 Jul; 27(7):667-70. PubMed ID: 7303501
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of probucol on bile composition in man.
    Jirsa M; Marecek Z; Kerdac V; Kucerova L
    Artery; 1982; 10(1):44-7. PubMed ID: 7092575
    [No Abstract]   [Full Text] [Related]  

  • 3. [Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].
    Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):3011-3. PubMed ID: 7443442
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of probucol on lipid and lipoprotein levels and serum apolipoproteins A1 and B in patients with hyperlipoproteinemia type II].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1985; 28(10):628-36. PubMed ID: 3938501
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia].
    Kawecka-Jaszcz K; Kocemba J; Wasowicz B; Król W
    Kardiol Pol; 1982; 25(5-6):377-82. PubMed ID: 6759746
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
    Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
    Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative effect of probucol and clofibrate in patients with primary hypercholesterolemia].
    Pasquali R; Melchionda N; Parenti M; Cavazzini MG; Biso P; Baraldi G; Sorrenti G; De Benedittis G; Labò G
    Clin Ter; 1982 Dec; 103(5):509-20. PubMed ID: 7160143
    [No Abstract]   [Full Text] [Related]  

  • 8. Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol.
    Tanno N; Oikawa S; Koizumi M; Kotake H; Hirakawa H; Kanazawa Y; Toyota T
    Dig Dis Sci; 1994 Jul; 39(7):1586-91. PubMed ID: 8026274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probucol and familial hypercholesterolemia.
    Dauignon J; Bouthillier D
    Can Med Assoc J; 1982 May; 126(9):1024-5. PubMed ID: 7074497
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of probucol on blood lipid level and lecithin acyltransferase activity in type II hyperlipoproteinemia].
    Sznajderman M; Kuczyńska K
    Pol Arch Med Wewn; 1981 Mar; 65(3):219-25. PubMed ID: 7255223
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of probucol on skin cholesterol concentrations in patients with type II hyperlipoproteineamia (author's transl)].
    Beaumont JL; Jacotot B; Buxtorf JC; Meliço-Silvestre AA; Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):2995-3000. PubMed ID: 7443438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol in patients resistant to the lipid-lowering effects of cholestyramine.
    Mann JI; Jelfs R; Cassels E; Barker K; Simpson HC; Carter RC
    Lancet; 1981 Feb; 1(8217):450. PubMed ID: 6110087
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias.
    Beaumont JL; Jacotot B; Buxtorf JC; Silvestre M; Beaumont V
    Artery; 1982; 10(1):71-87. PubMed ID: 7092577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary lipid composition in normo- and hyperlipoproteinemia.
    Ahlberg J; Angelin B; Einarsson K; Hellström K; Leijd B
    Gastroenterology; 1980 Jul; 79(1):90-4. PubMed ID: 7380228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the effect of probucol on blood lipids].
    Giannini SD; Forti N; Ziliotto EE
    Arq Bras Cardiol; 1981 Feb; 36(2):139-42. PubMed ID: 7325835
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of homozygous familial hypercholesterolaemia with probucol.
    Baker SG; Joffe BI; Mendelsohn D; Seftel HC
    S Afr Med J; 1982 Jul; 62(1):7-11. PubMed ID: 7089781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of probucol in man (author's transl)].
    Leutenegger M
    Nouv Presse Med; 1980 Oct; 9(40):2985-9. PubMed ID: 7443436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probucol, blood lipids and the ECG QTc interval.
    Graham I; Ronan G; Comerford D; Hickey N; Daly L; Mulcahy R
    Ir Med J; 1986 Feb; 79(2):45-7. PubMed ID: 3733408
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of probucol on blood lipids].
    Santos Rde O; Moriguchi Y
    Arq Bras Cardiol; 1982 Jul; 39(1):59-61. PubMed ID: 6762872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.